2-iodo-1H-imidazole → (S)-5-(1H-imidazol-2-ylethynyl)-N-[methyl(oxo)phenyl-lambda6-sulfanylidene]nicotinamide
반응식
[C:1]([C:3]1[CH:4]=[N:5][CH:6]=[C:7]([CH:20]=1)[C:8]([N:10]=[S@@:11]([CH3:19])(=[O:18])[C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)=[O:9])#[CH:2].I[C:22]1[NH:23][CH:24]=[CH:25][N:26]=1>>[NH:23]1[CH:24]=[CH:25][N:26]=[C:22]1[C:2]#[C:1][C:3]1[CH:4]=[N:5][CH:6]=[C:7]([CH:20]=1)[C:8]([N:10]=[S@@:11]([CH3:19])(=[O:18])[C:12]1[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=1)=[O:9]참가 물질
3
실험 절차
In a manner similar to that describe in Example 434, a mixture of (S)-5-ethynyl-N-[methyl(oxo)phenyl-λ6-sulfanylidene]nicotinamide and 2-iodo-1H-imidazole were reacted to give the title compound as a white solid (15 mg, 29%).
후처리
- customwere reacted
출처 및 근거
- ORD 기록
- ord-0069c148104348e7adccb155949eb00c
- 출처 데이터셋
- uspto-grants-2011_03
- 특허 번호
- US07915443B2
반응 노트
불러오는 중…